Research reported in this project was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U01AI151758.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Pasteur International Center for Research on Emerging Infectious Diseases> Publications

A new potential mosquito-borne virus: detection of Human-derived Jingmenvirus in several-species of mosquitoes from Yaoundé, Cameroon.

Immune profiling in subclinical secondary dengue-infected cases reveals adaptive immune signatures correlated to protection from severe dengue.

FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells.

Crimean-Congo Hemorrhagic Fever Outbreak in Podor, Northern Senegal in 2022: Two Independent Emergences and Unprecedented Mortality.

National burden and optimal vaccine policy for Japanese encephalitis virus in Bangladesh.

Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns.

Modeling the impact of vaccine campaigns on the epidemic transmission dynamics of chikungunya virus outbreaks.

Mosquito-based detection of retroviruses and arboviruses in Senegal: expanding the scope of xenosurveillance.

Re-emergence of Crimean Congo hemorrhagic fever virus in Kedougou, south-eastern Senegal in 2023: Epidemiological and zoological investigations of the first symptomatic human case.

Toward a deeper understanding of dengue: novel method for quantification and isolation of envelope protein epitope-specific antibodies.

Tick Species Infesting Livestock in Three Bioclimatic Areas of Senegal: Bioecology, Prevalence of Tick Infestation, Associated Categorical Factors and Crimean-Congo Haemorrhagic Fever Virus Infection.

Structural insights into tecovirimat antiviral activity and poxvirus resistance.

Antiviral activity of tecovirimat against monkeypox virus clades 1a, 1b, 2a, and 2b.

miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort.

Burden of rodent-borne viruses in rodents and zoonotic risk in human in Cambodia: a descriptive and observational study.

RSero: A user-friendly R package to reconstruct pathogen circulation history from seroprevalence studies.

Detection of Crimean-Congo hemorrhagic fever virus and Rift Valley fever virus antibodies in animal workers in Cameroon.

Spatiotemporal evolution and transmission dynamics of Alpha and Delta SARS-CoV-2 variants contributing to sequential outbreaks in Cambodia during 2021.

Insights into the virome of Hyalomma marginatum in the Danube Delta: a major vector of Crimean-Congo hemorrhagic fever virus in Eastern Europe.

Zika virus T-cell based 704/DNA vaccine promotes protection from Zika virus infection in the absence of neutralizing antibodies.

Review of dengue vectors in Cambodia: distribution, bionomics, vector competence, control and insecticide resistance.

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.

Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant.

Crimean-Congo haemorrhagic fever outbreak in Northern Senegal in 2022: Prevalence of the virus in livestock and ticks, associated risk factors and epidemiological implications.

Re-Emergence of Rift Valley Fever Virus Lineage H in Senegal in 2022: In Vitro Characterization and Impact on Its Global Emergence in West Africa.

Genomic characterization of a reemerging Chikungunya outbreak in Kedougou, Southeastern Senegal, 2023.

Increased frequencies of highly activated regulatory T cells skewed to a T helper 1-like phenotype with reduced suppressive capacity in dengue patients.

Reemergence of Sylvatic Dengue Virus Serotype 2 in Kedougou, Senegal, 2020.

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion

Emergence of Crimean-Congo Hemorrhagic Fever Virus in Eastern Senegal in 2022.

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.

Balancing functions of regulatory T cells in mosquito-borne viral infections.

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.

In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients.

Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies.

In-vitro assessment of cutaneous immune responses to aedes mosquito salivary gland extract and dengue virus in Cambodian individuals.

Unraveling the intricacies of host-pathogen interaction through single-cell genomics.

TMPRSS2 is a functional receptor for human coronavirus HKU1.

APOBEC3F Is a Mutational Driver of the Human Monkeypox Virus Identified in the 2022 Outbreak.

Untargeted metagenomic sequencing identifies Toscana virus in patients with idiopathic meningitis, southern Spain, 2015 to 2019.

Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients.

Longitudinal Study of Viral Diversity Associated with Mosquito Species Circulating in Cambodia.

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages

Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants

Aerosol exposure of live bird market workers to viable influenza A/H5N1 and A/H9N2 viruses, Cambodia.

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.

One assay to test them all: Multiplex assays for expansion of respiratory virus surveillance.

Genomic epidemiology of SARS-CoV-2 in Cambodia, January 2020 to February 2021.

Antibodies as drugs-a Keystone Symposia report.

Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic.

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.

Analysis of a Dengue Virus Outbreak in Rosso, Senegal 2021.

Temporal patterns of functionalanti‑dengue antibodies in dengueinfected individuals with differentdisease outcome or infectionhistory

Pestilence and famine: Continuing down the vicious cycle with COVID-19.

A Look inside the Replication Dynamics of SARS-CoV-2 in Blyth’s Horseshoe Bat (Rhinolophus lepidus) Kidney Cells

Editorial: Balanced and Unbalanced Immune Response to Dengue Virus in Disease Protection and Pathogenesis.

Antibody fucosylation predicts disease severity in secondary dengue infection.

NEWSLETTER

Newsletter Signup

Pasteur International Center for Research on Emerging Infectious Diseases
> Publications

Temporal patterns of functional
anti‑dengue antibodies in dengue
infected individuals with different
disease outcome or infection
history